New Market Research Report: Venezuela Pharmaceuticals & Healthcare Report Q2 2013
BMI View: While Maduro has the advantage of being Chavez's hand-picked successor, meaning he is likely to rise to power, the Venezuelan government's healthcare policies are unlikely to deviate from their current course over the short-to-medium term. We therefore maintain our current forecast for the country's healthcare expenditure and pharmaceutical market growth. However, we caution that political and economic uncertainties in the wake of Chavez's death could rein in public spending and put further downward pressure on multinationals' already diminishing...
View full press release